Literature DB >> 3190202

Comparative activities of cefuroxime, amoxicillin-clavulanic acid, ciprofloxacin, enoxacin, and ofloxacin against aerobic and anaerobic bacteria isolated from bite wounds.

E J Goldstein1, D M Citron.   

Abstract

We studied the comparative in vitro activities of 10 oral antimicrobial agents against 147 aerobic and 61 anaerobic bacteria making up species in 13 genera (Staphylococcus aureus, streptococci, Eikenella corrodens, Pasteurella multocida, Haemophilus-Actinobacillus spp., M-5, EF-4, Moraxella spp., Flavobacterium IIb, Bacteroides melaninogenicus, Bacteroides spp., Fusobacterium spp., and Peptostreptococcus spp.) that were isolated from bite wounds. Cefuroxime was generally greater than fourfold more active than cephalexin and cefadroxil against all aerobic isolates, including Pasteurella multocida. The fluoroquinolones were highly active against most aerobic isolates but were less active against anaerobic isolates. Ciprofloxacin was generally more active than either enoxacin or ofloxacin. Discrepancies of greater than 30% in the interpretation of susceptibilities between break points suggested by the National Committee for Clinical Laboratory Standards and those related to oral dose peak levels (one-half to one-quarter of maximum achievable concentrations) were noted in 14% (18 of 130) of the instances.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3190202      PMCID: PMC172366          DOI: 10.1128/AAC.32.8.1143

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  12 in total

1.  Lack of in vitro efficacy of oral forms of certain cephalosporins, erythromycin, and oxacillin against Pasteurella multocida.

Authors:  E J Goldstein; D M Citron; G A Richwald
Journal:  Antimicrob Agents Chemother       Date:  1988-02       Impact factor: 5.191

2.  Pasteurella multocida infection after animal bites.

Authors:  R W Goldstein; G L Goodhart; J E Moore
Journal:  N Engl J Med       Date:  1986-08-14       Impact factor: 91.245

Review 3.  Eikenella corrodens, a recently recognized pathogen: infections in medical-surgical patients and in association with methylphenidate abuse.

Authors:  G F Brooks; J M O'Donoghue; J P Rissing; K Soapes; J W Smith
Journal:  Medicine (Baltimore)       Date:  1974-09       Impact factor: 1.889

4.  Antibiotic susceptibility of Pasteurella multocida.

Authors:  C C Shikuma; G D Overturf
Journal:  Eur J Clin Microbiol       Date:  1985-10       Impact factor: 3.267

5.  Prophylactic antibiotics in common dog bite wounds: a controlled study.

Authors:  M Callaham
Journal:  Ann Emerg Med       Date:  1980-08       Impact factor: 5.721

Review 6.  Role of anaerobic bacteria in bite-wound infections.

Authors:  E J Goldstein; D M Citron; S M Finegold
Journal:  Rev Infect Dis       Date:  1984 Mar-Apr

7.  Bacteriology of human and animal bite wounds.

Authors:  E J Goldstein; D M Citron; B Wield; U Blachman; V L Sutter; T A Miller; S M Finegold
Journal:  J Clin Microbiol       Date:  1978-12       Impact factor: 5.948

8.  Dog bite wounds and infection: a prospective clinical study.

Authors:  E J Goldstein; D M Citron; S M Finegold
Journal:  Ann Emerg Med       Date:  1980-10       Impact factor: 5.721

9.  Microbiology of human and animal bite wounds in children.

Authors:  I Brook
Journal:  Pediatr Infect Dis J       Date:  1987-01       Impact factor: 2.129

10.  Eikenella corrodens in hand infections.

Authors:  E J Goldstein; M F Barones; T A Miller
Journal:  J Hand Surg Am       Date:  1983-09       Impact factor: 2.230

View more
  11 in total

Review 1.  Ofloxacin. A reappraisal of its antimicrobial activity, pharmacology and therapeutic use.

Authors:  P A Todd; D Faulds
Journal:  Drugs       Date:  1991-11       Impact factor: 9.546

2.  Comparative in vitro activities of DU-6859a, levofloxacin, ofloxacin, sparfloxacin, and ciprofloxacin against 387 aerobic and anaerobic bite wound isolates.

Authors:  E J Goldstein; D M Citron; S Hunt Gerardo; M Hudspeth; C V Merriam
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

3.  Activities of HMR 3004 (RU 64004) and HMR 3647 (RU 66647) compared to those of erythromycin, azithromycin, clarithromycin, roxithromycin, and eight other antimicrobial agents against unusual aerobic and anaerobic human and animal bite pathogens isolated from skin and soft tissue infections in humans.

Authors:  E J Goldstein; D M Citron; S Hunt Gerardo; M Hudspeth; C V Merriam
Journal:  Antimicrob Agents Chemother       Date:  1998-05       Impact factor: 5.191

4.  In vitro activity of Bay 12-8039, a new 8-methoxyquinolone, compared to the activities of 11 other oral antimicrobial agents against 390 aerobic and anaerobic bacteria isolated from human and animal bite wound skin and soft tissue infections in humans.

Authors:  E J Goldstein; D M Citron; M Hudspeth; S Hunt Gerardo; C V Merriam
Journal:  Antimicrob Agents Chemother       Date:  1997-07       Impact factor: 5.191

5.  Pasteurella multocida septicaemia in a patient on haemodialysis.

Authors:  Catherine Boinett; Armando Gonzalez
Journal:  BMJ Case Rep       Date:  2009-04-07

6.  Management of human and animal bite wound infection: an overview.

Authors:  Itzhak Brook
Journal:  Curr Infect Dis Rep       Date:  2009-09       Impact factor: 3.725

7.  Comparative susceptibilities of 173 aerobic and anaerobic bite wound isolates to sparfloxacin, temafloxacin, clarithromycin, and older agents.

Authors:  E J Goldstein; D M Citron
Journal:  Antimicrob Agents Chemother       Date:  1993-05       Impact factor: 5.191

Review 8.  Dog and cat bite-associated infections in children.

Authors:  S Esposito; I Picciolli; M Semino; N Principi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-02-14       Impact factor: 3.267

Review 9.  Fluoroquinolone antimicrobial agents.

Authors:  J S Wolfson; D C Hooper
Journal:  Clin Microbiol Rev       Date:  1989-10       Impact factor: 26.132

10.  Comparative in vitro activities of azithromycin, Bay y 3118, levofloxacin, sparfloxacin, and 11 other oral antimicrobial agents against 194 aerobic and anaerobic bite wound isolates.

Authors:  E J Goldstein; C A Nesbit; D M Citron
Journal:  Antimicrob Agents Chemother       Date:  1995-05       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.